US Stock MarketDetailed Quotes

HCA HCA Healthcare

Watchlist
  • 318.320
  • -14.750-4.43%
Trading Feb 26 14:27 ET
79.05BMarket Cap14.47P/E (TTM)

HCA Healthcare Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.48%10.51B
-4.30%2.56B
41.79%3.52B
-20.36%1.97B
36.94%2.47B
10.67%9.43B
5.82%2.67B
-17.91%2.48B
51.84%2.48B
34.05%1.8B
Net income from continuing operations
9.29%6.66B
-9.40%1.69B
16.24%1.48B
19.48%1.69B
16.79%1.8B
-10.87%6.09B
-29.67%1.86B
-5.13%1.28B
2.39%1.41B
5.32%1.54B
Operating gains losses
-380.00%-14M
2,885.71%195M
300.00%4M
-1,100.00%-12M
-1,440.00%-201M
100.41%5M
99.47%-7M
-166.67%-2M
-100.91%-1M
250.00%15M
Depreciation and amortization
7.64%3.31B
8.49%856M
9.49%842M
7.34%819M
5.16%795M
3.64%3.08B
5.20%789M
2.67%769M
3.39%763M
3.28%756M
Deferred tax
-90.39%22M
-47.02%89M
-208.62%-63M
-21.41%-448M
19.35%444M
-59.89%229M
-59.22%168M
52.63%58M
-64.00%-369M
7.51%372M
Other non cash items
26.34%283M
118.75%70M
21.05%46M
31.94%95M
-12.20%72M
23.08%224M
-11.11%32M
-24.00%38M
41.18%72M
82.22%82M
Change In working capital
76.81%-106M
-86.73%-422M
319.33%1.13B
-152.03%-282M
49.14%-530M
60.33%-457M
-205.41%-226M
-64.09%269M
206.69%542M
21.00%-1.04B
-Change in receivables
14.55%-799M
-11.34%-854M
171.73%340M
-386.76%-195M
-137.82%-90M
-17.31%-935M
-147.42%-767M
-890.00%-474M
156.67%68M
155.74%238M
-Change in inventory
365.08%334M
1.35%150M
833.33%252M
-66.67%-145M
135.98%77M
-113.56%-126M
232.14%148M
-94.76%27M
74.49%-87M
-76.86%-214M
-Change in payables and accrued expense
-40.56%359M
-28.24%282M
-25.14%536M
-89.66%58M
51.50%-517M
304.05%604M
12.93%393M
311.49%716M
1,293.62%561M
-38.26%-1.07B
Cash from discontinued investing activities
Operating cash flow
11.48%10.51B
-4.30%2.56B
41.79%3.52B
-20.36%1.97B
36.94%2.47B
10.67%9.43B
5.82%2.67B
-17.91%2.48B
51.84%2.48B
34.05%1.8B
Investing cash flow
Cash flow from continuing investing activities
7.22%-4.93B
15.72%-1.35B
-3.05%-1.35B
-5.97%-1.33B
21.55%-903M
-56.89%-5.32B
-101.39%-1.6B
-140.29%-1.31B
-4.32%-1.26B
-36.21%-1.15B
Net PPE purchase and sale
-2.76%-4.88B
-10.87%-1.29B
-3.84%-1.19B
-3.22%-1.28B
6.60%-1.12B
-7.94%-4.74B
12.40%-1.16B
-1.41%-1.15B
-14.91%-1.24B
-39.02%-1.2B
Net business purchase and sale
114.03%62M
92.44%-26M
36.99%-92M
-1,600.00%-34M
328.00%214M
-143.63%-442M
-164.06%-344M
-125.52%-146M
98.15%-2M
316.67%50M
Net investment purchase and sale
-2.68%-115M
63.41%-30M
-407.14%-71M
-433.33%-16M
115.38%2M
-900.00%-112M
-2,150.00%-82M
-216.67%-14M
75.00%-3M
-230.00%-13M
Net other investing changes
73.68%-5M
----
----
90.91%-1M
-111.11%-1M
9.52%-19M
-9.09%-12M
-600.00%-5M
-120.00%-11M
250.00%9M
Cash from discontinued investing activities
Investing cash flow
7.22%-4.93B
15.72%-1.35B
-3.05%-1.35B
-5.97%-1.33B
21.55%-903M
-56.89%-5.32B
-101.39%-1.6B
-140.29%-1.31B
-4.32%-1.26B
-36.21%-1.15B
Financing cash flow
Cash flow from continuing financing activities
-11.92%-4.58B
-108.18%-2.16B
90.28%-110M
8.76%-1.09B
-67.72%-1.22B
27.62%-4.09B
43.47%-1.04B
51.14%-1.13B
37.80%-1.2B
-270.59%-725M
Net issuance payments of debt
147.49%3.21B
-134.41%-64M
515.04%2.09B
708.75%647M
-22.17%537M
-60.60%1.3B
-40.95%186M
127.47%339M
-92.63%80M
-77.88%690M
Net common stock issuance
-58.54%-6.04B
-86.81%-1.7B
-57.46%-1.8B
-49.40%-1.37B
-39.48%-1.18B
45.56%-3.81B
40.09%-910M
-63.32%-1.14B
65.88%-915M
59.73%-846M
Cash dividends paid
-4.39%-690M
-3.13%-165M
-4.32%-169M
-4.27%-171M
-5.71%-185M
-1.23%-661M
-2.56%-160M
-1.25%-162M
-2.50%-164M
1.13%-175M
Net other financing activities
-15.05%-1.06B
-50.97%-234M
-36.69%-231M
-1.51%-202M
1.52%-388M
28.91%-917M
67.57%-155M
24.89%-169M
-17.06%-199M
5.52%-394M
Cash from discontinued financing activities
Financing cash flow
-11.92%-4.58B
-108.18%-2.16B
90.28%-110M
8.76%-1.09B
-67.72%-1.22B
27.62%-4.09B
43.47%-1.04B
51.14%-1.13B
37.80%-1.2B
-270.59%-725M
Net cash flow
Beginning cash position
2.97%935M
224.13%2.89B
-3.60%831M
52.49%1.28B
2.97%935M
-37.42%908M
-10.81%891M
0.47%862M
-64.49%842M
-37.42%908M
Current changes in cash
4,895.00%999M
-2,600.00%-950M
5,765.71%2.05B
-2,370.00%-454M
579.45%350M
103.82%20M
136.54%38M
-77.71%35M
101.33%20M
-107.89%-73M
Effect of exchange rate changes
-114.29%-1M
-183.33%-5M
166.67%4M
--1M
-114.29%-1M
135.00%7M
-53.85%6M
62.50%-6M
--0
240.00%7M
End cash Position
106.74%1.93B
106.74%1.93B
224.13%2.89B
-3.60%831M
52.49%1.28B
2.97%935M
2.97%935M
-10.81%891M
0.47%862M
-64.49%842M
Free cash flow
20.31%5.64B
-15.91%1.27B
74.47%2.32B
-44.08%690M
122.94%1.35B
13.57%4.69B
25.83%1.52B
-29.49%1.33B
124.36%1.23B
25.21%606M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.48%10.51B-4.30%2.56B41.79%3.52B-20.36%1.97B36.94%2.47B10.67%9.43B5.82%2.67B-17.91%2.48B51.84%2.48B34.05%1.8B
Net income from continuing operations 9.29%6.66B-9.40%1.69B16.24%1.48B19.48%1.69B16.79%1.8B-10.87%6.09B-29.67%1.86B-5.13%1.28B2.39%1.41B5.32%1.54B
Operating gains losses -380.00%-14M2,885.71%195M300.00%4M-1,100.00%-12M-1,440.00%-201M100.41%5M99.47%-7M-166.67%-2M-100.91%-1M250.00%15M
Depreciation and amortization 7.64%3.31B8.49%856M9.49%842M7.34%819M5.16%795M3.64%3.08B5.20%789M2.67%769M3.39%763M3.28%756M
Deferred tax -90.39%22M-47.02%89M-208.62%-63M-21.41%-448M19.35%444M-59.89%229M-59.22%168M52.63%58M-64.00%-369M7.51%372M
Other non cash items 26.34%283M118.75%70M21.05%46M31.94%95M-12.20%72M23.08%224M-11.11%32M-24.00%38M41.18%72M82.22%82M
Change In working capital 76.81%-106M-86.73%-422M319.33%1.13B-152.03%-282M49.14%-530M60.33%-457M-205.41%-226M-64.09%269M206.69%542M21.00%-1.04B
-Change in receivables 14.55%-799M-11.34%-854M171.73%340M-386.76%-195M-137.82%-90M-17.31%-935M-147.42%-767M-890.00%-474M156.67%68M155.74%238M
-Change in inventory 365.08%334M1.35%150M833.33%252M-66.67%-145M135.98%77M-113.56%-126M232.14%148M-94.76%27M74.49%-87M-76.86%-214M
-Change in payables and accrued expense -40.56%359M-28.24%282M-25.14%536M-89.66%58M51.50%-517M304.05%604M12.93%393M311.49%716M1,293.62%561M-38.26%-1.07B
Cash from discontinued investing activities
Operating cash flow 11.48%10.51B-4.30%2.56B41.79%3.52B-20.36%1.97B36.94%2.47B10.67%9.43B5.82%2.67B-17.91%2.48B51.84%2.48B34.05%1.8B
Investing cash flow
Cash flow from continuing investing activities 7.22%-4.93B15.72%-1.35B-3.05%-1.35B-5.97%-1.33B21.55%-903M-56.89%-5.32B-101.39%-1.6B-140.29%-1.31B-4.32%-1.26B-36.21%-1.15B
Net PPE purchase and sale -2.76%-4.88B-10.87%-1.29B-3.84%-1.19B-3.22%-1.28B6.60%-1.12B-7.94%-4.74B12.40%-1.16B-1.41%-1.15B-14.91%-1.24B-39.02%-1.2B
Net business purchase and sale 114.03%62M92.44%-26M36.99%-92M-1,600.00%-34M328.00%214M-143.63%-442M-164.06%-344M-125.52%-146M98.15%-2M316.67%50M
Net investment purchase and sale -2.68%-115M63.41%-30M-407.14%-71M-433.33%-16M115.38%2M-900.00%-112M-2,150.00%-82M-216.67%-14M75.00%-3M-230.00%-13M
Net other investing changes 73.68%-5M--------90.91%-1M-111.11%-1M9.52%-19M-9.09%-12M-600.00%-5M-120.00%-11M250.00%9M
Cash from discontinued investing activities
Investing cash flow 7.22%-4.93B15.72%-1.35B-3.05%-1.35B-5.97%-1.33B21.55%-903M-56.89%-5.32B-101.39%-1.6B-140.29%-1.31B-4.32%-1.26B-36.21%-1.15B
Financing cash flow
Cash flow from continuing financing activities -11.92%-4.58B-108.18%-2.16B90.28%-110M8.76%-1.09B-67.72%-1.22B27.62%-4.09B43.47%-1.04B51.14%-1.13B37.80%-1.2B-270.59%-725M
Net issuance payments of debt 147.49%3.21B-134.41%-64M515.04%2.09B708.75%647M-22.17%537M-60.60%1.3B-40.95%186M127.47%339M-92.63%80M-77.88%690M
Net common stock issuance -58.54%-6.04B-86.81%-1.7B-57.46%-1.8B-49.40%-1.37B-39.48%-1.18B45.56%-3.81B40.09%-910M-63.32%-1.14B65.88%-915M59.73%-846M
Cash dividends paid -4.39%-690M-3.13%-165M-4.32%-169M-4.27%-171M-5.71%-185M-1.23%-661M-2.56%-160M-1.25%-162M-2.50%-164M1.13%-175M
Net other financing activities -15.05%-1.06B-50.97%-234M-36.69%-231M-1.51%-202M1.52%-388M28.91%-917M67.57%-155M24.89%-169M-17.06%-199M5.52%-394M
Cash from discontinued financing activities
Financing cash flow -11.92%-4.58B-108.18%-2.16B90.28%-110M8.76%-1.09B-67.72%-1.22B27.62%-4.09B43.47%-1.04B51.14%-1.13B37.80%-1.2B-270.59%-725M
Net cash flow
Beginning cash position 2.97%935M224.13%2.89B-3.60%831M52.49%1.28B2.97%935M-37.42%908M-10.81%891M0.47%862M-64.49%842M-37.42%908M
Current changes in cash 4,895.00%999M-2,600.00%-950M5,765.71%2.05B-2,370.00%-454M579.45%350M103.82%20M136.54%38M-77.71%35M101.33%20M-107.89%-73M
Effect of exchange rate changes -114.29%-1M-183.33%-5M166.67%4M--1M-114.29%-1M135.00%7M-53.85%6M62.50%-6M--0240.00%7M
End cash Position 106.74%1.93B106.74%1.93B224.13%2.89B-3.60%831M52.49%1.28B2.97%935M2.97%935M-10.81%891M0.47%862M-64.49%842M
Free cash flow 20.31%5.64B-15.91%1.27B74.47%2.32B-44.08%690M122.94%1.35B13.57%4.69B25.83%1.52B-29.49%1.33B124.36%1.23B25.21%606M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.